Clinical Trial Update: DCVAC/OvCa After Standard-of-care Chemotherapy in Women With Relapse of Platinum-sensitive Epithelial Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update of DCVAC/OvCa as follow-up after standard chemotherapy in women with relapse of platinum-sensitive epithelial ovarian cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• DCVAC/OvCa

Snippet

Sponsor: SOTIO a.s. | Conditions: Ovarian Cancer Recurrent | Phase 2 | Status: COMPLETED